Sempra
NYSE:SREDiversified Utilities
-$0.05 today
- Market cap
- $50.69B
- Beta
- 0.58
- P/E (TTM)
- 28.5
- EPS (TTM)
- $3.17
- Dividend yield
- 2.87%
Volume 3.38M
Average 3.74M
SRE EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
SempraNYSE: SRE
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $1.55B rose 18.2% year over year, ahead of the +8.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 16.3% from the prior quarter. Over 3 fiscal years it compounded at +15.9% a year.
Context
- EBITDA amounted to 50.1% of revenue in FY2025, up 4.9 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of $9.39B (+36.7%) for the fiscal year ending Dec 2026, a step up from the +17.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.55B-16.3% QoQ
- Last fiscal yearDec 2025
- $6.87B+17.4% YoY
- LTMJun 2026
- $6.52B+8.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +18.2% | +17.5% | -0.8 pp |
| 1 year | +17.4% | +36.7% | +19.3 pp |
| 3-year CAGR | +15.9% | +18.3% | +2.4 pp |
| 5-year CAGR | +14.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 6.87B USD
- Year-over-year change
- +17.4%
- 4-year CAGR
- +20.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.87B | +17.4% |
| FY2024 | 2024-12-31 | 5.85B | -4.3% |
| FY2023 | 2023-12-31 | 6.12B | +38.5% |
| FY2022 | 2022-12-31 | 4.42B | +35.5% |
| FY2021 | 2021-12-31 | 3.26B | — |
EBITDA vs competitors
How SRE compares with its peers on the latest reported figures
- SRE's LTM Jun 2026 EBITDA of $6.52B is the 4th highest of the 11 companies compared; the peer median is $4.06B.
- Its year-over-year change of +8.6% is the 3rd highest of 11, against a peer median of +3.7%.
- EBITDA amounts to 47.9% of revenue for SRE, versus a peer median of 40.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $17.51B | +5.3% | +8.2% | 51.8% | |
| LTM Jun 2026 | $14.49B | +6.0% | +11.6% | 48.0% | |
| LTM Jun 2026 | $7.83B | -4.3% | +25.0% | 40.3% | |
| LTM Jun 2026 | $6.52B | +8.6% | +15.9% | 47.9% | |
| LTM Sep 2026 | $4.16B | -10.3% | +19.3% | 33.8% | |
| LTM Jun 2026 | $4.11B | -0.0% | +6.3% | 40.6% | |
| LTM Jun 2026 | $4.01B | +17.1% | +4.5% | 41.7% | |
| LTM Jun 2026 | $3.29B | +2.1% | +9.5% | 37.4% | |
| LTM Sep 2026 | $2.85B | -8.7% | +10.2% | 31.1% | |
| LTM Jun 2026 | $2.67B | +14.5% | +17.0% | 54.2% | |
| LTM Jun 2026 | $659M | +6.4% | +13.6% | 34.3% | |
| Peer median (excluding SRE) | $4.06B | +3.7% | +10.9% | 40.4% | |
Competitors are the stored peer set for SRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.06B | 15.55B | 15.8B | 12.96B | 13.71B |
| Cost of Revenue | 9.42B | 11.39B | 12.06B | 9.43B | 9.72B |
| Gross Profit | 3.64B | 4.16B | 3.75B | 3.52B | 4B |
| Gross Margin | 27.9% | 26.8% | 23.7% | 27.2% | 29.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 596M | 635M | 677M | 693M | 744M |
| Operating Expenses | 596M | 635M | 677M | 693M | 744M |
| Depreciation & Amortization | 1.86B | 2.02B | 2.23B | 2.44B | 2.56B |
| EBITDA | 3.26B | 4.42B | 6.12B | 5.85B | 6.87B |
| EBITDA Margin | 25.0% | 28.4% | 38.7% | 45.1% | 50.1% |
| Operating Income | 3.05B | 3.53B | 3.07B | 2.83B | 3.25B |
| Operating Margin | 23.3% | 22.7% | 19.4% | 21.8% | 23.7% |
| Interest Income | 69M | 75M | 89M | 61M | 103M |
| Interest Expense | 1.19B | 1.06B | 1.26B | 1.3B | 1.53B |
| Other Income / Expenses | (1.49B) | (685M) | 1.04B | 888M | (480M) |
| Income Before Tax | 1.56B | 2.84B | 4.11B | 3.72B | 2.77B |
| Pre-Tax Margin | 12.0% | 18.3% | 26.0% | 28.7% | 20.2% |
| Income Tax Expense | 99M | 556M | 490M | 219M | 701M |
| Net Income | 1.32B | 2.14B | 3.08B | 2.86B | 1.84B |
| Net Margin | 10.1% | 13.8% | 19.5% | 22.1% | 13.4% |
| EPS (Basic) | 2.01 | 3.32 | 4.81 | 4.44 | 2.75 |
| EPS (Diluted) | 2.00 | 3.31 | 4.79 | 4.42 | 2.75 |
| Weighted Avg Shares | 623.51M | 630.32M | 630.3M | 633.8M | 652.7M |
| Weighted Avg Shares (Diluted) | 626.07M | 632.76M | 632.73M | 637.94M | 652.7M |
Sempra
NYSE:SRE
Intrinsic Alpha fair value
Locked
Current Price
$77.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.